Muscle Strength and Walking Speed in Obese Adults With Type 2 Diabetes
Measures grip strength and walking speed in obese adults with long-standing diabetes.
Plain-language title generated from the registry record
Registry title: Sarcopenia Risk in Obese T2DM Patients
Key facts
- Where
- Bandırma, TürkiyeSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 75 with type 2 diabetes for at least 5 years and obesity. It measures muscle strength, walking speed and the risk of muscle loss.
- Age
- 18 to 75 years
- Sex
- All sexes can join.
- Disease stage
- Type 2 diabetes diagnosed for 5 years or longer, with a BMI of 30 kg/m² or more.
- Earlier treatment
- Not stated. People who had a major surgery in the last 6 months cannot join.
Main reasons for not taking part
- Type 1 diabetes or other specific types of diabetes
- Major surgery in the last 6 months
- Cancer with current cancer treatment
- Neuromuscular disorder such as stroke, myopathy or Parkinson's disease
- Pregnancy
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT07905274, who can take part
Where in Türkiye
- Bandırma Onyedi Eylul University Faculty of MedicineBandırma, TürkiyeContact: Nurten NAS KIRDARNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Bandırma Onyedi Eylül University
- Trial code
- NCT07905274
- Record updated
- 29 October 2026
- Original description
This study aims to measure handgrip strength, walking speed, and the risk of muscle wasting in obese patients who have had diabetes for 5 years or longer, and to evaluate the relationship of these measures with factors that may influence them, such as the duration of diabetes, blood test results, body mass index, and the waist-to-height ratio.Read full original descriptionShow less
Evaluation of Muscle Strength, Gait Speed, Sarcopenia Risk, and Associated Factors in Obese Patients With Type 2 Diabetes
This study aims to measure handgrip strength, walking speed, and the risk of muscle wasting in obese patients who have had diabetes for 5 years or longer, and to evaluate the relationship of these measures with factors that may influence them, such as the duration of diabetes, blood test results, body mass index, and the waist-to-height ratio.
Inclusion: Being between 18 and 75 years of age; Having a diagnosis of Type 2 diabetes mellitus for ≥ 5 years; Having a BMI ≥ 30 kg/m²; Being willing to participate in the study and providing written informed consent.
Exclusion: Having undergone a major surgical procedure within the last 6 months; Having a diagnosis of malignancy and currently receiving oncological treatment; Having type 1 diabetes mellitus or other specific types of diabetes; Having a neuromuscular disorder (such as stroke, paraplegia, tetraplegia, myopathy, muscular dystrophy, amyotrophic lateral sclerosis, Parkinson's disease, etc.) that could significantly affect muscle strength or walking performance; Being unable to complete the tests due to a lower-extremity amputation or an orthopedic condition; Having an acute infection or an acute systemic illness requiring hospitalization; Having a cognitive impairment or a psychiatric condition that hinders communication; Pregnancy.